Insights

Strong Industry Focus Sprint Bioscience specializes in early-stage cancer drug development, presenting opportunities to collaborate with pharmaceutical companies seeking innovative oncology candidates or licensing promising assets.

Recent Asset Divestment The sale of a major cancer program to Gilead Sciences for 414 million USD indicates significant valuation and potential for partnership in high-value oncology therapeutics, making them a key player for licensing or acquisition discussions.

Strategic Collaborations Partnerships with entities like the Experimental Drug Development Centre and Day One Biopharmaceuticals highlight opportunities for joint research, co-development, or technology licensing to accelerate drug discovery processes.

Emerging Focus Areas Expansion into inflammatory diseases and AML through new drug programs opens doors for suppliers of research tools, clinical trial services, and targeted treatments tailored to these indications.

Growing R&D Investment With moderate revenue and recent funding around 2.3 million USD, Sprint Bioscience is actively investing in innovation, creating potential for sales of research services, laboratory equipment, or specialized compounds to support their development programs.

Sprint Bioscience Tech Stack

Sprint Bioscience uses 8 technology products and services including Linkedin Sign-in, jQuery, Google Maps, and more. Explore Sprint Bioscience's tech stack below.

  • Linkedin Sign-in
    Identity Verification
  • jQuery
    Javascript Libraries
  • Google Maps
    Maps
  • LinkedIn
    Online Community Software
  • Java
    Programming Languages
  • PHP
    Programming Languages
  • reCAPTCHA
    Security
  • Apache
    Web Servers

Media & News

Sprint Bioscience's Email Address Formats

Sprint Bioscience uses at least 1 format(s):
Sprint Bioscience Email FormatsExamplePercentage
First.Last@sprintbioscience.comJohn.Doe@sprintbioscience.com
50%
First.Last@sprintbioscience.comJohn.Doe@sprintbioscience.com
50%

Frequently Asked Questions

Where is Sprint Bioscience's headquarters located?

Minus sign iconPlus sign icon
Sprint Bioscience's main headquarters is located at 7 Hälsovägen Huddinge, Stockholm 141 57 Sweden. The company has employees across 2 continents, including EuropeNorth America.

What is Sprint Bioscience's phone number?

Minus sign iconPlus sign icon
You can contact Sprint Bioscience's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sprint Bioscience's official website and social media links?

Minus sign iconPlus sign icon
Sprint Bioscience's official website is sprintbioscience.com and has social profiles on LinkedInCrunchbase.

What is Sprint Bioscience's SIC code NAICS code?

Minus sign iconPlus sign icon
Sprint Bioscience's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Sprint Bioscience have currently?

Minus sign iconPlus sign icon
As of February 2026, Sprint Bioscience has approximately 43 employees across 2 continents, including EuropeNorth America. Key team members include Ceo: J. E.Chief Business Officer: A. W.Co-Founder And Cso: M. A.. Explore Sprint Bioscience's employee directory with LeadIQ.

What industry does Sprint Bioscience belong to?

Minus sign iconPlus sign icon
Sprint Bioscience operates in the Pharmaceutical Manufacturing industry.

What technology does Sprint Bioscience use?

Minus sign iconPlus sign icon
Sprint Bioscience's tech stack includes Linkedin Sign-injQueryGoogle MapsLinkedInJavaPHPreCAPTCHAApache.

What is Sprint Bioscience's email format?

Minus sign iconPlus sign icon
Sprint Bioscience's email format typically follows the pattern of First.Last@sprintbioscience.com. Find more Sprint Bioscience email formats with LeadIQ.

How much funding has Sprint Bioscience raised to date?

Minus sign iconPlus sign icon
As of February 2026, Sprint Bioscience has raised $2.3M in funding. The last funding round occurred on Mar 15, 2016 for $2.3M.

When was Sprint Bioscience founded?

Minus sign iconPlus sign icon
Sprint Bioscience was founded in 2009.

Sprint Bioscience

Pharmaceutical ManufacturingStockholm, Sweden11-50 Employees

Sprint Bioscience is an innovative company focused on early-stage drug development, providing novel drug candidates within the cancer field.

Section iconCompany Overview

Headquarters
7 Hälsovägen Huddinge, Stockholm 141 57 Sweden
Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2009
Employees
11-50

Section iconFunding & Financials

  • $2.3M

    Sprint Bioscience has raised a total of $2.3M of funding over 4 rounds. Their latest funding round was raised on Mar 15, 2016 in the amount of $2.3M.

  • $1M$10M

    Sprint Bioscience's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $2.3M

    Sprint Bioscience has raised a total of $2.3M of funding over 4 rounds. Their latest funding round was raised on Mar 15, 2016 in the amount of $2.3M.

  • $1M$10M

    Sprint Bioscience's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.